Merck KGaA (OTCMKTS:MKKGY - Get Free Report) shares gapped down prior to trading on Monday . The stock had previously closed at $26.54, but opened at $25.69. Merck KGaA shares last traded at $25.63, with a volume of 4,820 shares trading hands.
Merck KGaA Trading Down 2.9%
The stock has a market capitalization of $16.66 billion, a PE ratio of 12.21, a PEG ratio of 1.98 and a beta of 0.92. The company has a quick ratio of 0.83, a current ratio of 1.31 and a debt-to-equity ratio of 0.23. The business's 50-day moving average is $26.44 and its two-hundred day moving average is $27.73.
Merck KGaA (OTCMKTS:MKKGY - Get Free Report) last announced its quarterly earnings results on Thursday, May 15th. The company reported $0.59 earnings per share for the quarter, beating analysts' consensus estimates of $0.50 by $0.09. Merck KGaA had a net margin of 13.23% and a return on equity of 9.61%. The firm had revenue of $5.89 billion during the quarter, compared to analysts' expectations of $5.32 billion. On average, analysts anticipate that Merck KGaA will post 1.87 earnings per share for the current fiscal year.
Merck KGaA Increases Dividend
The firm also recently announced a dividend, which was paid on Wednesday, May 7th. Stockholders of record on Wednesday, April 30th were issued a $0.3382 dividend. This represents a dividend yield of 1.25%. This is a boost from Merck KGaA's previous dividend of $0.32. The ex-dividend date of this dividend was Tuesday, April 29th. Merck KGaA's dividend payout ratio is presently 16.11%.
About Merck KGaA
(
Get Free Report)
Merck KGaA operates as a science and technology company in Germany. It operates through Life Science, Healthcare, and Electronics segments. The company's Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as industrial sector.
Featured Articles
Before you consider Merck KGaA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Merck KGaA wasn't on the list.
While Merck KGaA currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.